… falciparum AMA-A- and CSP-derived peptides as a malaria vaccine, ten Tanzanian adults
… living in a malaria-endemic region were immunized with one or two doses of the vaccine on …

… consensus that major improvements are necessary to develop a vaccine that is likely to have
a greater epidemiological impact in endemic areas. Since the development of RTS,S in the …

… many areas without a vaccine. Malaria vaccines have long been a research priority, but only
this year the World Health Organization announced that a malaria vaccine would advance …

… A highly effective malaria vaccine would be one way to achieve further reductions in the global
malaria … confers immunity against malaria suggests that a malaria vaccine is conceivable [ …

… features, including their potential for rapid development, scalability, and flexibility in
antigen design, make them a promising avenue for malaria vaccine development. This review …

… Malaria vaccine development entered a new era in 2015 … the first human anti-parasite
vaccine to pass regulatory scrutiny. … of vaccines for malaria elimination, or a so-called vaccine to …

… We explore next-generation vaccines designed using new knowledge of malaria … a
decision-making process that prioritizes malaria vaccine candidates for development in a …

… published a position paper on malaria vaccines (2), with emphasis on the RTS,S/AS01 …
also was a tendency for RTS,S to be associated with a higher risk of fatal malaria in girls (malaria …

… Here, we present evidence in humans that malaria can be prevented from 4 to 36 weeks
after a single administration of a monoclonal antibody against the major protein covering the …

… no vaccine has been deployed for widespread use against a … The RTS,S/AS01 vaccine is
the first licensed malaria vaccine to … A novel approach that can be studied for malaria vaccines …